Please login to the form below

Not currently logged in
Email:
Password:

NHS England

This page shows the latest NHS England news and features for those working in and with pharma, biotech and healthcare.

UK plans to launch new national health agency focused on tackling pandemics

UK plans to launch new national health agency focused on tackling pandemics

The UK Health Security Agency (UKHSA) will protect against future health threats, and will take over the COVID-19 pandemic response from Public Health England (PHE) and NHS Test and Trace. ... At that time, the agency was set to be led by Baroness Dido

Latest news

More from news
Approximately 79 fully matching, plus 474 partially matching documents found.

Latest Intelligence

  • Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England

    focus on the single technology appraisal [STA] and the highly specialised technology [HST] frameworks), or, second, via NHS England specialised commissioning. ... 80.9%; 17/21) compared with drugs evaluated by NHS England for specialised commissioning (61

  • Rethinking our approach to infectious disease preparedness Rethinking our approach to infectious disease preparedness

    NHS England will now pay pharma companies a guaranteed amount for access to new drugs to treat resistant infections for up to ten years, a reward potentially totalling £100m.

  • NICE – but not enough NICE – but not enough

    issued – with NHS organisations having a maximum of 90 calendar days after NICE publication to make a treatment available. ... However, by the end of the 90-day period, the product had been adopted on just 44% of NHS formularies in England.

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    Victory of the people in the fight against COVID-19. NHS sees record numbers respond to call for volunteers. ... Our team is now working flat out with colleagues in NHS England to process the many thousands of applications we’ve received, so we can get

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    In the UK, NHS England is collaborating with the National Institute for Health and Care Excellence (NICE) on a pilot project under which NHS England will evaluate and procure two AMR ... It will test a ‘subscription’ style model that pays

More from intelligence
Approximately 4 fully matching, plus 62 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 14 partially matching documents found.

Latest from PMHub

  • WHITE PAPER: Why do men die younger? WHITE PAPER: Why do men die younger?

    13. Public Health England and the NHS have a distinct lack of mission statements on the topic. ... calls for increased efforts from all stakeholders: from NHS England, to GPs, to men themselves.

  • Integrated NHS finances: what do they mean for High Cost Drugs?

    NHS England (NHSE) Specialised Commissioning will continue to retain the budget for cancer and certain rare diseases. ... For these services, most High Cost Drugs will still be contracted via NHS England.

  • The heavy toll of COVID-19 on cancer patients

    NHS England also announced that stereotactic ablative radiotherapy (SABR) will be available to access the entire NHS by the end of the financial year. ... cancer patients and staff at a frequency of once a week. Neither tThe government nor the NHS have

  • Harness the power of data to map new patient pathways

    routes. The NHS needs to be very data driven to map these developments and understand local populations and what they need. ... Hospital Episode Statistics (HES) data, which contains details of all admissions, outpatient appointments and A&E visits to

  • Let's be ambitious for patients and life sciences investment in Global Britain Let's be ambitious for patients and life sciences investment in Global Britain

    One argument against NICE reform is its potential greater impact on NHS budgets. ... As well as NICE reform, industry could seek Government commitments to curtail NHS England’s cost-squeezing tenders which create no actual saving to the NHS or taxpayer

More from PMHub
Approximately 1 fully matching, plus 61 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....

Infographics